RECENT NEWS

Health technology provider Alcidion has appointed digital health leader Will Smart as a non-executive director.

InnoScot Health will recommence its educational series of webinars on Wednesday 25 September with a session aimed at supporting healthcare innovators in achieving success.

Healthcare innovators are being urged to take advantage of grants ranging from £10,000 to £100,000 to support projects focusing on 5G and advanced wireless technologies in Glasgow.

1 in 5 deaths globally is associated with sepsis. To coincide with World Sepsis Day, Vygon is raising awareness of the importance of advanced haemodynamic monitoring.

The Association for Perioperative Practice (AfPP) has announced that from 1st September 2024 perioperative students will be given free membership, and all existing student members will benefit too.

​Primel, a leading provider of innovative infection prevention solutions, is pleased to announce it has been accepted into the Clean Hospitals Association, furthering its commitment to promoting hygiene-first healthcare practices. This strategic alliance marks a significant milestone in Primel's ongoing efforts to improve healthcare standards globally by providing Surface Active Therapeutic technologies to directly confront the highest vectors of infection within the healthcare system.

Central Medical Supplies (CMS) has appointed Ary Abadian and Amanda Stonehouse as Regional Account Managers. CMS is renowned for its critical care and neonatal equipment, which it has been supplying to the NHS and private sector acute hospitals for over thirty years.

Registrations are now underway for the NHS Providers Annual Conference and Exhibition, which offers insights and networking opportunities to help NHS staff excel in leadership roles. Every year, the event brings together over 800 senior leaders from NHS Trusts, system partners and key stakeholders.

Researchers have discovered a more accurate and timely way to deliver life-saving drug therapies to the brain, laying the groundwork for more effective treatment of brain tumours and other neurological diseases.

The Infection Prevention Society’s Annual Conference, Infection Prevention 2024, is taking place at the ICC, Birmingham from the 23 -25 September.

New research by the Health Foundation provides the first robust causal evidence that NHS surgical hubs increase treatment volumes and reduce the length of time patients spend in hospital. By delivering more operations in a shorter time, they could speed up efforts to tackle waiting lists

On the 5th and 6th of September this year, Queen Mary University of London’s School of Engineering and Materials Science will host the 16th BioMedEng conference, welcoming over 400 Biomedical engineers, researchers, clinical specialists, government and industry representatives.

The Patients Association, a leading independent charity campaigning for improvements in health and social care for patients, has announced the appointment of two new trustees, Professor Alf Collins and Tom Grinyer.

A team of Korean researchers has made a breakthrough that will greatly enhance the efficiency of respiratory disease research, by creating artificial lungs.

The Dengue vaccine has an efficacy rate of over 50% in reducing disease cases, with lasting effects and a very good safety profile.

When COVID-19 booster vaccines are in short supply, prioritising the elderly over other age groups for booster vaccination results in the lowest loss of life.

A new study has revealed important information about how a patient’s testosterone level can help protect them from severe COVID-19. Previous research involving Swansea University investigated how sex hormones are likely to be important determinants of COVID-19 severity.

New research presented at the ESC Congress 2024 in London shows that women in the menopause transition period show changes in their blood cholesterol profiles which could have an adverse impact on their cardiovascular health.

​Action on Pre-eclampsia (APEC) has welcomed the Scottish Government’s announcement of dedicated funding for pre-eclampsia testing in every Health Board – helping to protect thousands of pregnant mothers and babies in Scotland. This means that, for the first time, expectant mothers in Scotland will soon have access to placental growth factor (PlGF) testing, a simple blood test to help diagnose pre-eclampsia that has been available in England since 2016.

Cardiovascular disease (CVD) remains the most common cause of death across Europe but while CVD mortality rates are generally decreasing, the decline is much less in middle-income than in high-income countries.